Announcement
The International Society for Stem Cell Application announced that it would participate in the IMCAS 2022 World Congress in Paris. The June 3-5 meeting brought together professionals in dermatology, plastic surgery, and aesthetic medicine. ISSCA said it would use its presence to discuss GCELL technology, physician training, and a separate regenerative-medicine congress planned for Istanbul later that year.
The society's announcement identified booth 999 as a place for attendees to learn about its educational programs. It framed cellular approaches as a topic for professional exchange at the event. Promotional statements in the original announcement about the safety or effectiveness of technologies should not be mistaken for independent clinical findings or approval for use in a particular jurisdiction.
The congress and booth information relate only to 2022. Clinicians looking for present educational events should use ISSCA's current schedule, and patients should ask qualified medical professionals about the evidence and regulatory status of a proposed treatment. An event appearance describes participation in a conference, not a recommendation of any procedure.